Trial Profile
Immunogenicity After Two Doses of Meningococcal Outer Membrane Vesicle Vaccine MenBVac.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Apr 2013
Price :
$35
*
At a glance
- Drugs Meningococcal vaccine group B OMV (Primary)
- Indications Meningococcal group B infections
- Focus Pharmacodynamics
- 14 Apr 2009 Actual end date (May 2008) added as reported by ClinicalTrials.gov.
- 14 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 May 2008 Status changed from recruiting to in prgoress, reported by ClinicalTrials.gov.